Fig. 2From: Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicineEfficacy of the currently available treatments in HGSOC. Data are expressed as the median rate of freedom from disease progression and from death at a certain interval timeBack to article page